Bora Pharmaceuticals Co., Ltd. (TPE:6472)
417.00
+9.00 (2.21%)
Apr 29, 2026, 1:30 PM CST
Bora Pharmaceuticals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5,077 | 5,829 | 3,053 | 3,281 | 910.75 | Upgrade
|
| Short-Term Investments | 38.37 | 67.86 | 342.63 | 247.62 | - | Upgrade
|
| Trading Asset Securities | 20.28 | 20.28 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 5,136 | 5,917 | 3,396 | 3,529 | 910.75 | Upgrade
|
| Cash Growth | -13.21% | 74.25% | -3.77% | 287.48% | 35.94% | Upgrade
|
| Accounts Receivable | 9,260 | 10,482 | 4,028 | 6,120 | 824.77 | Upgrade
|
| Other Receivables | 344.91 | 766.08 | 82.61 | 286.38 | 33.23 | Upgrade
|
| Receivables | 9,604 | 11,248 | 4,111 | 6,407 | 858.01 | Upgrade
|
| Inventory | 3,410 | 5,502 | 2,157 | 1,991 | 928.64 | Upgrade
|
| Prepaid Expenses | 675.46 | 591 | 801.43 | 242.47 | 63.07 | Upgrade
|
| Other Current Assets | 511.69 | 118.63 | 138.63 | 71.58 | 31.87 | Upgrade
|
| Total Current Assets | 19,338 | 23,377 | 10,604 | 12,241 | 2,792 | Upgrade
|
| Property, Plant & Equipment | 11,183 | 12,510 | 7,494 | 7,300 | 4,067 | Upgrade
|
| Long-Term Investments | 5,929 | 236.33 | 21.26 | 62.03 | - | Upgrade
|
| Goodwill | 2,664 | 3,618 | 3,010 | 983.59 | - | Upgrade
|
| Other Intangible Assets | 3,580 | 3,920 | 2,665 | 1,164 | 171.05 | Upgrade
|
| Long-Term Deferred Tax Assets | 1,170 | 1,190 | 1,045 | 829.64 | 243.78 | Upgrade
|
| Other Long-Term Assets | 849.81 | 657.62 | 294.85 | 181.01 | 98.65 | Upgrade
|
| Total Assets | 44,714 | 45,510 | 25,134 | 22,761 | 7,372 | Upgrade
|
| Accounts Payable | 925.1 | 792.34 | 380.45 | 454.74 | 235.81 | Upgrade
|
| Accrued Expenses | 111.46 | 132.63 | 30.86 | 29.33 | 321.24 | Upgrade
|
| Short-Term Debt | 3,950 | 2,598 | 767.51 | 2,161 | 645.48 | Upgrade
|
| Current Portion of Long-Term Debt | 1,691 | 1,189 | 630.5 | 725.63 | 222.09 | Upgrade
|
| Current Portion of Leases | 80.62 | 116.6 | 106.04 | 75.31 | 17.54 | Upgrade
|
| Current Income Taxes Payable | 321.05 | 484.33 | 987.43 | 238.65 | 50.58 | Upgrade
|
| Current Unearned Revenue | 262.52 | 245.6 | 224.6 | 85.69 | 20.47 | Upgrade
|
| Other Current Liabilities | 5,979 | 8,250 | 5,102 | 6,725 | 327.91 | Upgrade
|
| Total Current Liabilities | 13,321 | 13,808 | 8,229 | 10,496 | 1,841 | Upgrade
|
| Long-Term Debt | 11,796 | 14,324 | 2,724 | 4,037 | 1,028 | Upgrade
|
| Long-Term Leases | 708.9 | 745.96 | 763.33 | 596.88 | 305.97 | Upgrade
|
| Long-Term Unearned Revenue | 88.87 | - | - | 4.18 | - | Upgrade
|
| Pension & Post-Retirement Benefits | 99.39 | 129.04 | 115.36 | 136.41 | 136.28 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 988.55 | 1,256 | 783.9 | 742.85 | 609.77 | Upgrade
|
| Other Long-Term Liabilities | 239.08 | 323.59 | 753.09 | 1,608 | 298.57 | Upgrade
|
| Total Liabilities | 27,242 | 30,586 | 13,368 | 17,621 | 4,220 | Upgrade
|
| Common Stock | 1,274 | 1,031 | 1,014 | 753.82 | 684.12 | Upgrade
|
| Additional Paid-In Capital | 6,056 | 4,408 | 3,318 | 1,236 | 1,026 | Upgrade
|
| Retained Earnings | 8,346 | 7,020 | 4,729 | 2,549 | 1,466 | Upgrade
|
| Treasury Stock | -134.29 | -43.18 | -50.97 | -53.09 | - | Upgrade
|
| Comprehensive Income & Other | -159.75 | 362.83 | 74.66 | 42.2 | -23.26 | Upgrade
|
| Total Common Equity | 15,381 | 12,779 | 9,085 | 4,528 | 3,153 | Upgrade
|
| Minority Interest | 2,091 | 2,144 | 2,681 | 612.13 | - | Upgrade
|
| Shareholders' Equity | 17,472 | 14,923 | 11,766 | 5,140 | 3,153 | Upgrade
|
| Total Liabilities & Equity | 44,714 | 45,510 | 25,134 | 22,761 | 7,372 | Upgrade
|
| Total Debt | 18,227 | 18,973 | 4,991 | 7,596 | 2,219 | Upgrade
|
| Net Cash (Debt) | -13,091 | -13,056 | -1,595 | -4,067 | -1,308 | Upgrade
|
| Net Cash Per Share | -69.41 | -92.49 | -12.84 | -34.34 | -11.20 | Upgrade
|
| Filing Date Shares Outstanding | 126.99 | 123.39 | 121.33 | 117.01 | 117.32 | Upgrade
|
| Total Common Shares Outstanding | 126.99 | 123.39 | 121.33 | 117.01 | 117.32 | Upgrade
|
| Working Capital | 6,017 | 9,569 | 2,375 | 1,745 | 951.22 | Upgrade
|
| Book Value Per Share | 121.12 | 103.57 | 74.88 | 38.70 | 26.87 | Upgrade
|
| Tangible Book Value | 9,137 | 5,241 | 3,410 | 2,381 | 2,981 | Upgrade
|
| Tangible Book Value Per Share | 71.95 | 42.47 | 28.10 | 20.35 | 25.41 | Upgrade
|
| Land | 3,758 | 3,824 | 3,424 | 3,397 | 1,984 | Upgrade
|
| Buildings | 7,289 | 7,963 | 1,945 | 1,905 | 1,393 | Upgrade
|
| Machinery | 3,870 | 6,113 | 2,814 | 2,390 | 859.79 | Upgrade
|
| Construction In Progress | 809.38 | 527.38 | 115.84 | 76.72 | 11.73 | Upgrade
|
| Leasehold Improvements | - | - | - | 205.29 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.